BIOGEN IDEC - Dusseldorf Stock Exchang
BIOGEN IDEC - Dusseldorf Stock Exchang operates in Diversified Metals & Mining.
BIOGEN IDEC - Dusseldorf Stock Exchang (IDP) - Total Liabilities
Latest total liabilities as of September 2024: €11.95 Billion EUR
Based on the latest financial reports, BIOGEN IDEC - Dusseldorf Stock Exchang (IDP) has total liabilities worth €11.95 Billion EUR as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
BIOGEN IDEC - Dusseldorf Stock Exchang - Total Liabilities Trend (2016–2023)
This chart illustrates how BIOGEN IDEC - Dusseldorf Stock Exchang's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
BIOGEN IDEC - Dusseldorf Stock Exchang Competitors by Total Liabilities
The table below lists competitors of BIOGEN IDEC - Dusseldorf Stock Exchang ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Locate Technologies Ltd
AU:LOC
|
Australia | AU$5.58 Million |
|
Orege Société Anonyme
PA:OREGE
|
France | €60.58 Million |
|
Trisula Textile Industries Tbk PT
JK:BELL
|
Indonesia | Rp292.58 Billion |
|
Sonoma Resources Inc.
V:SRQ
|
Canada | CA$69.89K |
|
PFEIFFER VACU TECH
BE:PFV
|
Germany | €403.52 Million |
|
Khaitan (India) Limited
NSE:KHAITANLTD
|
India | ₹416.66 Million |
|
Ever Shine Textile Industry
JK:ESTI
|
Indonesia | Rp504.43 Billion |
Liability Composition Analysis (2016–2023)
This chart breaks down BIOGEN IDEC - Dusseldorf Stock Exchang's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.26 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.73 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.42 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BIOGEN IDEC - Dusseldorf Stock Exchang's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BIOGEN IDEC - Dusseldorf Stock Exchang (2016–2023)
The table below shows the annual total liabilities of BIOGEN IDEC - Dusseldorf Stock Exchang from 2016 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | €12.05 Billion | +7.88% |
| 2022-12-31 | €11.17 Billion | -13.56% |
| 2021-12-31 | €12.92 Billion | -7.29% |
| 2020-12-31 | €13.93 Billion | +0.27% |
| 2019-12-31 | €13.90 Billion | +13.36% |
| 2018-12-31 | €12.26 Billion | +10.88% |
| 2017-12-31 | €11.05 Billion | +2.85% |
| 2016-12-31 | €10.75 Billion | -- |